The complement system as a main actor in the pathogenesis of obstetric antiphospholipid syndrome

被引:8
作者
Alijotas-Reig, Jaume [1 ,2 ]
机构
[1] UAB, Hosp Univ Vall Hebron, Unidad Enfermedades Sistem Autoinmunes, Serv Med Interna 1, Barcelona, Spain
[2] Univ Autonoma Barcelona, Fac Med, Dept Med, E-08193 Barcelona, Spain
来源
MEDICINA CLINICA | 2010年 / 134卷 / 01期
关键词
Antiphospholipid antibodies; Antiphospholipid syndrome; Complement levels; Inflammation; Recurrent miscarriage; Tissue factor; RECURRENT PREGNANCY LOSS; TISSUE FACTOR; FETAL LOSS; ANTICARDIOLIPIN ANTIBODIES; LUPUS ANTICOAGULANTS; THROMBOSIS; WOMEN; ACTIVATION; HEPARIN; MARKERS;
D O I
10.1016/j.medcli.2009.05.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pregnancy losses are the main obstetrical complications of the obstetric anti phospholipid syndrome (obstetric-APS). Classically, they have been strongly attributed to thrombosis and further placental infarcts. But in some cases is not possible to show evidence of decidual thrombosis or placental vasculopathy, and sometimes inflammatory signs are present. Besides, the prevalence of systemic thrombosis is low in obstetric APS patients. Some cases have low plasma C4/C3 levels. Animal models show a local inflammatory mechanism. The beta 2-glycoprotein-1/anti-beta 2-glycoprotein-1 complexes activate both, classical and alternative complement pathways. Complement proteins may injure trophoblast cells, recruiting and activating monocytes and neutrophils. Free radicals and proteolytic enzymes could also attack trophoblastic cells. In addition, an amplifier loop between the tissue factor, inflammatory cells and complement proteins could exist. Overall, these diverse mechanisms may explain both, inflammatory and thrombophilic placental alterations. In the end, the role played in this binomial by certain pro-inflammatory cytokines, mainly TNF-alpha, remains to clarify. (C) 2009 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:30 / 34
页数:5
相关论文
共 39 条
  • [1] Antinuclear autoantibodies, complement level, hypergammaglobulinemia and spontaneous intrauterine hematoma in pregnant women
    Alijotas, J
    Izquierdo, M
    Serra, B
    Cusido, MT
    Ribera, M
    Carrera, JM
    [J]. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2003, 50 (01) : 1 - 6
  • [2] Are anti-beta2-Glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
    Alijotas-Reig, Jaume
    Casellas-Caro, Manel
    Ferrer-Oliveras, Raquel
    Llurba-Olive, Elisa
    Hermosilla, Eduard
    Vilardell-Tarres, Miquel
    Cabero-Roura, Lluis
    [J]. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2008, 60 (03) : 229 - 237
  • [3] Circulating microparticles, lupus anticoagulant and recurrent miscarriages
    Alijotas-Reig, Jaume
    Palacio-Garcia, Carles
    Vilardell-Tarres, Miquel
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2009, 145 (01) : 22 - 26
  • [4] ALIJOTASREIG J, 2009, FERTIL STERIL 0316
  • [5] Editorial - Diffuse alveolar hemorrhage: A nonthrornbotic antiphospholipid lung syndrome?
    Asherson, RA
    Cervera, R
    Wells, AU
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2005, 35 (03) : 138 - 142
  • [6] Asherson RA, 2006, J RHEUMATOL, V33, P1038
  • [7] Antiphosphatidylserine antibodies and reproductive failure
    Blank, M
    Shoenfeld, Y
    [J]. LUPUS, 2004, 13 (09) : 661 - 665
  • [8] Antiphospholipid syndrome: Obstetric diagnosis, management, and controversies
    Branch, DW
    Khamashta, MA
    [J]. OBSTETRICS AND GYNECOLOGY, 2003, 101 (06) : 1333 - 1344
  • [9] Burrow GN., 1999, Medical complications during pregnancy
  • [10] C3 and C4 hypocomplementemia in obstetric antiphospholipid syndrome
    Carbone, J.
    Sarmiento, E.
    Rodriguez-Molina, J.
    Fernandez-Cruz, E.
    [J]. REVISTA CLINICA ESPANOLA, 2008, 208 (03): : 170 - 171